NEW CEPHALOSPORINS AND PROCESSES FOR THEIR PREPARATION

Novel antibacterially active cephalosporins of the formula in which R1 denotes hydrogen, optionally substituted alkyl, a substituted or unsubstituted phenyl ring, a polycyclic aromatic ring or an optionally substituted heterocyclic 5- or 6-member ring having 1-4 heteroatoms, R2 represents hydrogen,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DR ROLF ANGERBAUER, DR GUNTHER KINAST, DR HANS-JOACHIM ZEILER, DR KARL GEORG METZGER, DR MICHAEL BOBERG, DR WILFRIED SCHROCK
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DR ROLF ANGERBAUER
DR GUNTHER KINAST
DR HANS-JOACHIM ZEILER
DR KARL GEORG METZGER
DR MICHAEL BOBERG
DR WILFRIED SCHROCK
description Novel antibacterially active cephalosporins of the formula in which R1 denotes hydrogen, optionally substituted alkyl, a substituted or unsubstituted phenyl ring, a polycyclic aromatic ring or an optionally substituted heterocyclic 5- or 6-member ring having 1-4 heteroatoms, R2 represents hydrogen, C1-C4-alkyl, C1-C4-alkenyl, halogen, C1-C4-alkoxy, C1-C4-alkylthio, hydroxymethyl, formyloxymethyl, C1-C4-alkylcarbonyloxymethyl, aminocarbonyloxymethyl, pyridiniummethyl, 4-carbamoylpyridiniummethyl, 4-sulphonylethylpyridiniummethyl, 4-carboxylmethylpyridiniummethyl or heterocyclylthiomethyl, heterocyclyl representing a radical of the formula +TR wherein R8 denotes hydrogen, methyl, 2-dimethylaminoethyl, carboxymethyl, sulphomethyl, carboxyethyl or sulphoethyl and R9 denotes hydrogen or methyl, or pharmaceutically tolerated salts or esters thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GB2133013B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GB2133013B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GB2133013B3</originalsourceid><addsrcrecordid>eNrjZDDzcw1XcHYN8HD08Q8O8A_y9AtWcPRzUQgI8nd2DQ52DVZw8w9SCPFw9QwCirkGOAY5hnj6-_EwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknh3JyNDY2MDQ2MnY8IqAI9mJys</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW CEPHALOSPORINS AND PROCESSES FOR THEIR PREPARATION</title><source>esp@cenet</source><creator>DR ROLF ANGERBAUER ; DR GUNTHER KINAST ; DR HANS-JOACHIM ZEILER ; DR KARL GEORG METZGER ; DR MICHAEL BOBERG ; DR WILFRIED SCHROCK</creator><creatorcontrib>DR ROLF ANGERBAUER ; DR GUNTHER KINAST ; DR HANS-JOACHIM ZEILER ; DR KARL GEORG METZGER ; DR MICHAEL BOBERG ; DR WILFRIED SCHROCK</creatorcontrib><description>Novel antibacterially active cephalosporins of the formula in which R1 denotes hydrogen, optionally substituted alkyl, a substituted or unsubstituted phenyl ring, a polycyclic aromatic ring or an optionally substituted heterocyclic 5- or 6-member ring having 1-4 heteroatoms, R2 represents hydrogen, C1-C4-alkyl, C1-C4-alkenyl, halogen, C1-C4-alkoxy, C1-C4-alkylthio, hydroxymethyl, formyloxymethyl, C1-C4-alkylcarbonyloxymethyl, aminocarbonyloxymethyl, pyridiniummethyl, 4-carbamoylpyridiniummethyl, 4-sulphonylethylpyridiniummethyl, 4-carboxylmethylpyridiniummethyl or heterocyclylthiomethyl, heterocyclyl representing a radical of the formula +TR wherein R8 denotes hydrogen, methyl, 2-dimethylaminoethyl, carboxymethyl, sulphomethyl, carboxyethyl or sulphoethyl and R9 denotes hydrogen or methyl, or pharmaceutically tolerated salts or esters thereof.</description><edition>4</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1986</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19861126&amp;DB=EPODOC&amp;CC=GB&amp;NR=2133013B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19861126&amp;DB=EPODOC&amp;CC=GB&amp;NR=2133013B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DR ROLF ANGERBAUER</creatorcontrib><creatorcontrib>DR GUNTHER KINAST</creatorcontrib><creatorcontrib>DR HANS-JOACHIM ZEILER</creatorcontrib><creatorcontrib>DR KARL GEORG METZGER</creatorcontrib><creatorcontrib>DR MICHAEL BOBERG</creatorcontrib><creatorcontrib>DR WILFRIED SCHROCK</creatorcontrib><title>NEW CEPHALOSPORINS AND PROCESSES FOR THEIR PREPARATION</title><description>Novel antibacterially active cephalosporins of the formula in which R1 denotes hydrogen, optionally substituted alkyl, a substituted or unsubstituted phenyl ring, a polycyclic aromatic ring or an optionally substituted heterocyclic 5- or 6-member ring having 1-4 heteroatoms, R2 represents hydrogen, C1-C4-alkyl, C1-C4-alkenyl, halogen, C1-C4-alkoxy, C1-C4-alkylthio, hydroxymethyl, formyloxymethyl, C1-C4-alkylcarbonyloxymethyl, aminocarbonyloxymethyl, pyridiniummethyl, 4-carbamoylpyridiniummethyl, 4-sulphonylethylpyridiniummethyl, 4-carboxylmethylpyridiniummethyl or heterocyclylthiomethyl, heterocyclyl representing a radical of the formula +TR wherein R8 denotes hydrogen, methyl, 2-dimethylaminoethyl, carboxymethyl, sulphomethyl, carboxyethyl or sulphoethyl and R9 denotes hydrogen or methyl, or pharmaceutically tolerated salts or esters thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1986</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDzcw1XcHYN8HD08Q8O8A_y9AtWcPRzUQgI8nd2DQ52DVZw8w9SCPFw9QwCirkGOAY5hnj6-_EwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknh3JyNDY2MDQ2MnY8IqAI9mJys</recordid><startdate>19861126</startdate><enddate>19861126</enddate><creator>DR ROLF ANGERBAUER</creator><creator>DR GUNTHER KINAST</creator><creator>DR HANS-JOACHIM ZEILER</creator><creator>DR KARL GEORG METZGER</creator><creator>DR MICHAEL BOBERG</creator><creator>DR WILFRIED SCHROCK</creator><scope>EVB</scope></search><sort><creationdate>19861126</creationdate><title>NEW CEPHALOSPORINS AND PROCESSES FOR THEIR PREPARATION</title><author>DR ROLF ANGERBAUER ; DR GUNTHER KINAST ; DR HANS-JOACHIM ZEILER ; DR KARL GEORG METZGER ; DR MICHAEL BOBERG ; DR WILFRIED SCHROCK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GB2133013B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1986</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DR ROLF ANGERBAUER</creatorcontrib><creatorcontrib>DR GUNTHER KINAST</creatorcontrib><creatorcontrib>DR HANS-JOACHIM ZEILER</creatorcontrib><creatorcontrib>DR KARL GEORG METZGER</creatorcontrib><creatorcontrib>DR MICHAEL BOBERG</creatorcontrib><creatorcontrib>DR WILFRIED SCHROCK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DR ROLF ANGERBAUER</au><au>DR GUNTHER KINAST</au><au>DR HANS-JOACHIM ZEILER</au><au>DR KARL GEORG METZGER</au><au>DR MICHAEL BOBERG</au><au>DR WILFRIED SCHROCK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW CEPHALOSPORINS AND PROCESSES FOR THEIR PREPARATION</title><date>1986-11-26</date><risdate>1986</risdate><abstract>Novel antibacterially active cephalosporins of the formula in which R1 denotes hydrogen, optionally substituted alkyl, a substituted or unsubstituted phenyl ring, a polycyclic aromatic ring or an optionally substituted heterocyclic 5- or 6-member ring having 1-4 heteroatoms, R2 represents hydrogen, C1-C4-alkyl, C1-C4-alkenyl, halogen, C1-C4-alkoxy, C1-C4-alkylthio, hydroxymethyl, formyloxymethyl, C1-C4-alkylcarbonyloxymethyl, aminocarbonyloxymethyl, pyridiniummethyl, 4-carbamoylpyridiniummethyl, 4-sulphonylethylpyridiniummethyl, 4-carboxylmethylpyridiniummethyl or heterocyclylthiomethyl, heterocyclyl representing a radical of the formula +TR wherein R8 denotes hydrogen, methyl, 2-dimethylaminoethyl, carboxymethyl, sulphomethyl, carboxyethyl or sulphoethyl and R9 denotes hydrogen or methyl, or pharmaceutically tolerated salts or esters thereof.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_GB2133013B
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NEW CEPHALOSPORINS AND PROCESSES FOR THEIR PREPARATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A28%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DR%20ROLF%20ANGERBAUER&rft.date=1986-11-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGB2133013B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true